Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
T••••• H••••• I••••••••
T••••• H••••• I•••••••• is a private equity firm that partners with high-growth, commercial-stage healthcare companies and invests in the medical device, healthcare services and technology, specialty pharmaceuticals, and biotechnology sectors. Our investments in people, products, technologies, and services have a significant impact on global health.
both early and growth/opportunity families, reported GAV $70M
- Headquarters
- Palm Beach Gardens, FLadviserinfo.sec.gov
- Office address
- 11770 U.S. HIGHWAY 1 - SUITE 503, Palm Beach Gardens, FL, 33408adviserinfo.sec.gov
- Business phone
- 561-200-3300adviserinfo.sec.gov
- Website
- t•••••••••.com
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 30, 2026
- Private funds reported
- 4 (4 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $58.8Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- L• T••••• • S• W••••• T•••• J•••• L• T••••• I••••••••• T•••• U•• D•••• 0••••••••• F•• S••• W••••• (Member Of T••••• H••••• I•••••••• Of Florida Llc), NA; L• T••••• • E• S•••••••• T•••• J•••• L• T••••• I••••••••• T•••• U•• D•••• 0••••••••• F•• E•••••••• S•••••••• (Member Of T••••• H••••• I•••••••• Of Florida Llc), NA; L• T••••• • J••• T••••• T•••• J•••• L• T••••• I••••••••• T•••• U•• D•••• 0••••••••• F•• J••• T••••• (Member Of T••••• H••••• I•••••••• Of Florida Llc), NA
- business phone
- 561-200-3300adviserinfo.sec.govpublished by the subject
- Sectors
- healthcare, biotech, medtech
- Stages
- not stated or not yet read
- Geography
- global
- Check size
- not stated; DFX does not estimate checks from round sizes
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| T••••• G••••• F••• I•• L••• | Growth fund | 2019 form d first sale | Mature | $12.1M Apr 16, 2024 | 15 | $16.1M | Aug 3, 2021 |
| T••••• G••••• F•••• L••• | Growth fund | 2014 form d first sale | Harvest | $15.4M Apr 16, 2024 | 25 | $21.4M of $200M | Jan 30, 2015 |
| T••••••••• C•••••• F•••• I••• L••• | Fund | unknown | Unknown | $33.8M Apr 16, 2024 | 35 | unknown | unknown |
| T••••• G••••• F••• C••••• F•••••• L••• | Growth fund | unknown | Unknown | $8.5M Apr 16, 2024 | 3 | unknown | unknown |
| T••••••••• C•••••• F•••• I•• L••• | Fund | unknown | Wound down | $21.0M Mar 27, 2020 | 90 | unknown | unknown |
| T••••••••• C•••••• F•••• I•• L••• | Fund | unknown | Wound down | $21.0M Mar 27, 2020 | 90 | unknown | unknown |
| T• J•••••• C•••••• F•••• L• | Fund | unknown | Wound down | $1.4M Mar 31, 2014 | 37 | unknown | unknown |
| T••••• O••••••••• F•••• L••• | Opportunity fund | unknown | Wound down | $637,000 Mar 28, 2018 | 12 | unknown | unknown |
| T••••• O••••••••• F•••• I•• L•• | Opportunity fund | unknown | Wound down | $619,234 Mar 25, 2019 | 13 | unknown | unknown |
| T• J•••••• C•••••• F••• I•• L••• | Fund | unknown | Wound down | $62,976 Mar 27, 2020 | 2 | unknown | unknown |
| T• L••••••••• F•••• L••• | Fund | unknown | Wound down | $48,965 Mar 27, 2020 | 2 | unknown | unknown |
| T• O••••• C•••••• F•••• L••• | Fund | unknown | Wound down | $36,077 Mar 27, 2020 | 2 | unknown | unknown |
2 departed (kept with end dates)
- N••• M•••• · Chief Financial Officer · Jun 1, 2008 to Mar 28, 2013 Inference
- C••• H• L•••••• · Senior Vice President And Assistant Secretary Of T••••••••• & Co., Inc. · Sep 1, 2008 to Mar 29, 2016 Inference
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| S••••• | portfolio listing | unknown | unknown | unknown | unknown | Sep 16, 2026 | Fact Venture organization websites (about, team, portfolio, thesis, news pages) |
- Mar 29, 2016T••••• G••••• F••• C••••• F•••••• L••• first reported on Form ADV by T••••• H••••• I•••••••• (Venture Capital Fund), GAV $16,460,000Fund first reported on Form ADVFundsFactT••••• G••••• F••• C••••• F•••••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2016C••• H• L•••••• (Senior Vice President And Assistant Secretary Of T••••••••• & Co., Inc.) no longer on Schedule A of T••••• H••••• I••••••••
- Mar 31, 2015T• J•••••• C•••••• F•••• L• no longer reported on Form ADV by T••••• H••••• I••••••••Fund no longer reportedFundsInferenceT• J•••••• C•••••• F•••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2015T••••• G••••• F•••• L••• first reported on Form ADV by T••••• H••••• I•••••••• (Venture Capital Fund), GAV $5,828,000Fund first reported on Form ADVFundsFactT••••• G••••• F•••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2013N••• M•••• (Chief Financial Officer) no longer on Schedule A of T••••• H••••• I••••••••
- Mar 29, 2012T••••• O••••••••• F•••• L••• first reported on Form ADV by T••••• H••••• I•••••••• (Venture Capital Fund), GAV $6,157,000Fund first reported on Form ADVFundsFactT••••• O••••••••• F•••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2012T••••••••• C•••••• F•••• I••• L••• first reported on Form ADV by T••••• H••••• I•••••••• (Venture Capital Fund), GAV $33,846,000Fund first reported on Form ADVFundsFactT••••••••• C•••••• F•••• I••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2012T••••• O••••••••• F•••• I•• L•• first reported on Form ADV by T••••• H••••• I•••••••• (Venture Capital Fund), GAV $3,950,000Fund first reported on Form ADVFundsFactT••••• O••••••••• F•••• I•• L••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2012T••••••••• C•••••• F•••• I•• L••• first reported on Form ADV by T••••• H••••• I•••••••• (Venture Capital Fund), GAV $17,838,000Fund first reported on Form ADVFundsFactT••••••••• C•••••• F•••• I•• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2012TD O••••• Capital Fund, LP first reported on Form ADV by T••••• H••••• I•••••••• (Venture Capital Fund), GAV $2,066,000Fund first reported on Form ADVFundsFactT• O••••• C•••••• F•••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2012TD L••••••••• Capital Fund, LP first reported on Form ADV by T••••• H••••• I•••••••• (Venture Capital Fund), GAV $17,129,000Fund first reported on Form ADVFundsFactT• L••••••••• F•••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2012TD J•••••• Capital Fund II, LP first reported on Form ADV by T••••• H••••• I•••••••• (Venture Capital Fund), GAV $22,278,000Fund first reported on Form ADVFundsFactT• J•••••• C•••••• F••• I•• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2012T••••• H••••• I•••••••• first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2012T• J•••••• C•••••• F•••• L• first reported on Form ADV by T••••• H••••• I•••••••• (Venture Capital Fund), GAV $1,297,000Fund first reported on Form ADVFundsFactT• J•••••• C•••••• F•••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 1, 2011S•••••••• M••• joined Schedule A of T••••• H••••• I•••••••• as Controller Of T••••• H••••• I•••••••• Of Florida Llc
- Jul 1, 2005E•••••••• D• T••••• joined Schedule A of T••••• H••••• I•••••••• as Trustee
- Jul 1, 2005S••• D•••••• T••••• joined Schedule A of T••••• H••••• I•••••••• as Trustee
- Jul 1, 2005J••• L••••• T••••• joined Schedule A of T••••• H••••• I•••••••• as Trustee
- Jul 1, 2005L•••• T••••• joined Schedule A of T••••• H••••• I•••••••• as Trustee
- Dec 1, 1999M•••••• D• M•••••• joined Schedule A of T••••• H••••• I•••••••• as Chief Accounting Officer / Controller Of T••••••••• & Co., Inc.
- Sep 15, 2026Multi-stage venture firm (confirmed, 95%, cls-1)both early and growth/opportunity families, reported GAV $70M
- Sep 12, 2026Multi-stage venture firm (confirmed, 95%, cls-1)both early and growth/opportunity families, reported GAV $54M